These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22579864)

  • 1. The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence.
    Usonis V; Ivaskeviciene I; Desselberger U; Rodrigo C;
    Vaccine; 2012 Jun; 30(31):4596-605. PubMed ID: 22579864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population.
    Antunes H; Afonso A; Iturriza M; Martinho I; Ribeiro C; Rocha S; Magalhães C; Carvalho L; Branca F; Gray J
    J Clin Virol; 2009 May; 45(1):76-8. PubMed ID: 19375980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network.
    Iturriza-Gómara M; Dallman T; Bányai K; Böttiger B; Buesa J; Diedrich S; Fiore L; Johansen K; Koopmans M; Korsun N; Koukou D; Kroneman A; László B; Lappalainen M; Maunula L; Marques AM; Matthijnssens J; Midgley S; Mladenova Z; Nawaz S; Poljsak-Prijatelj M; Pothier P; Ruggeri FM; Sanchez-Fauquier A; Steyer A; Sidaraviciute-Ivaskeviciene I; Syriopoulou V; Tran AN; Usonis V; VAN Ranst M; DE Rougemont A; Gray J
    Epidemiol Infect; 2011 Jun; 139(6):895-909. PubMed ID: 20707941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus A genotype P[4]G2: genetic diversity and reassortment events among strains circulating in Brazil between 2005 and 2009.
    Gómez MM; de Mendonça MC; Volotão Ede M; Tort LF; da Silva MF; Cristina J; Leite JP
    J Med Virol; 2011 Jun; 83(6):1093-106. PubMed ID: 21503926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?
    Matthijnssens J; Nakagomi O; Kirkwood CD; Ciarlet M; Desselberger U; Van Ranst M
    Expert Rev Vaccines; 2012 Nov; 11(11):1347-54. PubMed ID: 23249234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of the indirect effects of rotavirus vaccination.
    Van Effelterre T; Soriano-Gabarró M; Debrus S; Claire Newbern E; Gray J
    Epidemiol Infect; 2010 Jun; 138(6):884-97. PubMed ID: 20028612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving epidemiology of rotavirus gastroenteritis in central Portugal with modest vaccine coverage.
    Rodrigues F; Iturriza-Gómara M; Marlow R; Gray J; Nawaz S; Januário L; Finn A
    J Clin Virol; 2013 Feb; 56(2):129-34. PubMed ID: 23238239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world impact of rotavirus vaccination.
    Patel MM; Steele D; Gentsch JR; Wecker J; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S1-5. PubMed ID: 21183833
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
    Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccination in central Europe.
    Mészner Z; Anca I; André F; Chlibek R; Čižman M; Grzesiowski P; Mangarov A; Pokorn M; Prymula R; Richter D; Salman N; Šimurka P; Tamm E; Tešović G; Urbancikova I; Usonis V; Zavadska D;
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):586-96. PubMed ID: 23708638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.
    Bibera GL; Chen J; Pereira P; Benninghoff B
    Vaccine; 2020 Jul; 38(35):5591-5600. PubMed ID: 32651115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.
    Iturriza-Gómara M; Dallman T; Bányai K; Böttiger B; Buesa J; Diedrich S; Fiore L; Johansen K; Korsun N; Kroneman A; Lappalainen M; László B; Maunula L; Matthinjnssens J; Midgley S; Mladenova Z; Poljsak-Prijatelj M; Pothier P; Ruggeri FM; Sanchez-Fauquier A; Schreier E; Steyer A; Sidaraviciute I; Tran AN; Usonis V; Van Ranst M; de Rougemont A; Gray J
    J Infect Dis; 2009 Nov; 200 Suppl 1():S215-21. PubMed ID: 19821712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus Strain Surveillance in Estonia After Introduction of Rotavirus Universal Mass Vaccination.
    Kõivumägi K; Soeorg H; Toompere K; Kallas E; Jõegeda EL; Lass E; Huik K; Lutsar I;
    Pediatr Infect Dis J; 2021 May; 40(5):489-494. PubMed ID: 33847298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus disease and vaccination: impact on genotype diversity.
    Matthijnssens J; Bilcke J; Ciarlet M; Martella V; Bányai K; Rahman M; Zeller M; Beutels P; Van Damme P; Van Ranst M
    Future Microbiol; 2009 Dec; 4(10):1303-16. PubMed ID: 19995190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Burden of acute rotavirus gastroenteritis (RV-AGE) in Germany: a comparison of federal statistics and epidemiological data].
    Forster J; Hammerschmidt T
    Gesundheitswesen; 2007 Apr; 69(4):227-32. PubMed ID: 17533565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ever-changing landscape of rotavirus serotypes.
    O'Ryan M
    Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S60-2. PubMed ID: 19252426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.